Related Content
- Goodwin InsightsFebruary 6, 2023
In the Metaverse, Existing Healthcare Rules Apply
- AlertFebruary 6, 2023
EU Technology Regulation: Watch List for 2023 and Beyond
- AlertFebruary 6, 2023
Telehealth Issues to Watch in 2023
- AlertFebruary 1, 2023
Federal Court of Appeals Rejects HHS Stance on Section 340B Contract Pharmacies
- In the PressJanuary 27, 2023
Top 5 Compliance Issues for Medtech Firms Transitioning To Data-Enabled Solutions (MedCity News)
- AlertJanuary 26, 2023
CMS Issues First Request for Public Comments on the Medicare Drug Price Negotiation Program “Small Biotech” Exception – Due March 27, 2023
- Goodwin InsightsJanuary 20, 2023
Implications of Abortion Laws for Fertility Services
- AlertJanuary 18, 2023
USPTO Launches the Cancer Moonshot Expedited Examination Pilot Program
- Press ReleaseFebruary 7, 2023
Fulcrum Therapeutics Closes $125 Million Public Offering of Common Stock
- In the PressFebruary 2, 2023
Goodwin Adds 4 Partners In Philadelphia And NY (Law360)
- Press ReleaseFebruary 1, 2023
Goodwin Continues Expansion in Philadelphia and New York with Four Life Sciences Partners
- In the PressFebruary 1, 2023
Goodwin Adds Four More Partners to Life Sciences Team (Bloomberg Law)
- In the PressFebruary 1, 2023
Goodwin Adds Four More Partners with About 20 Associates Expected to Follow (Philadelphia Business Journal)
- In the PressFebruary 1, 2023
4 More Partners Bolster Goodwin's Life Sciences Practice in Philadelphia, NY (Law.com)
- In the PressFebruary 1, 2023
Law Firm Goodwin Adds Four More Partners (Reuters)
- In the PressFebruary 1, 2023
Jon Olsen Joins Goodwin's Tech M&A Team (Law360)